6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Improvement of the breeding and feeding habitats for the Lesser Spotted Eagle (Aquila pomarina), as well as for the Corn Crake (Crex crex) and the Aquatic Warbler (Acrocephalus paludicola) in the SPA âSchorfheide-Chorinâ. (Schreiadler Schorfheide)
Date du début: 1 oct. 2011, Date de fin: 31 mars 2017,
Background
The presence of the lesser spotted eagle (Aquila pomarina) in Schorfheide-Chorin, northeast Germany, is of great significance. The species can be found 25 km away from the project area, but it has very complex habitat requirements. As a result its numbers are in decline in Brandenburg and Mecklenburg-West Pomerania, where there is increasing lo...
Voir le projet
5
Participants partenaires
TERMINÉ
IMmune MOdulating strategies for treatment of MErkel cell Carcinoma (IMMOMEC)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2016,
"Merkel cell carcinoma (MCC) is a highly aggressive, often lethal neuroendocrine cancer of the skin associated with the recently discovered, common Merkel cell polyomavirus (MCV). With an incidence of 0.44 per 100,000 MCC is a very rare cancer. Notably, however, although MCC is 40 times less common than malignant melanoma, MCC has a dramatically higher mortality rate than melanoma rendering MCC to...
Voir le projet
11
Participants partenaires
TERMINÉ
Strategies for the Improvement of Critical infrastructure Resilience to Electromagnetic Attacks (STRUCTURES)
Date du début: 1 juil. 2012, Date de fin: 31 oct. 2015,
Security and quality of life in industrialized countries depend on continuous and coordinate performance of a set of infrastructures (energy systems, ICT systems, transportation etc) which can be therefore defined “critical infrastructures” (CI).“STRUCTURES - Strategies for The impRovement of critical infrastrUCTUre Resilience to Electromagnetic attackS” aims at analyzing possible effects of elect...
Voir le projet
13
Participants partenaires
TERMINÉ
Safety Evaluation of Adverse Reactions in Diabetes (SAFEGUARD)
Date du début: 1 oct. 2011, Date de fin: 30 sept. 2015,
"In 2010 a widely marketed drug for the treatment of type 2 diabetes (T2DM) (rosiglitazone) was taken from the market as it was associated with an increased risk of myocardial infarction, a T2DM complication it was actually supposed to prevent. This example shows several things. First, the approval requirements do not guarantee a longer term positive benefit risk profile. Second, large scale postm...
Voir le projet
19
Participants partenaires
TERMINÉ
Profiling Responders In Antibody Therapies (PRIAT)
Date du début: 1 nov. 2012, Date de fin: 31 oct. 2014,
"Therapeutic antibodies are the largest and fastest growing class of pharmaceutical biotechnology products, with annual sales above 30 billion US$. In some cases, antibody products have revolutionized the management of patients, e.g. TNF-blocking antibodies in Arthritis or Rituxan in lymphoma. However, for most antibody therapies, only a subset of patients benefit from treatment. Thus, there is an...
Voir le projet
8
Participants partenaires
TERMINÉ
In der Sozialwirtschaft sind europaweit mehr als 50.000 Personen anleitend in SIEs(Social Integration Enterprises) tätig, die über 1 Mio. Menschen bei der Verbesserungihrer beruflichen Situation und Integration begleiten und qualifizieren; diesesFachpersonal ist zuständig für fachliche und überfachliche Qualifizierung der befristetBeschäftigten und für die Dokumentation der vorhandenen Fähigkeiten...
Voir le projet